The Galleri® Test

A single blood test screening for a shared cancer signal across 50+ cancer types

Why it matters: the screening gap patients face today

  • Screening is recommended for only a small number of cancer types in the UK — including breast, cervical, bowel and targeted lung cancer screening

  • Around 6% of all cancers are currently diagnosed through screening programs

  • The UK has some of the lowest cancer survival2 and some of the highest rates of emergency cancer presentation3 among comparable high-income countries

  • Many cancers are not found until symptoms appear, and nearly half of staged-cancers are diagnosed at later stages, when they can be harder to treat.

How the Galleri® test can address this

Galleri is a multi-cancer early detection (MCED) test developed by GRAIL. Rather than looking for one cancer at a time, it analyses methylation patterns in cell-free DNA (cfDNA) in the bloodstream to identify a signal associated with cancer.

When a cancer signal is detected, the test correctly predicts the cancer signal origin in 93% of cases.

Its particular value is that most of these cancers have no recommended screening program in the UK at all. Galleri is designed to complement — not replace — established programmes such as breast, cervical and bowel screening.

  • Screen for 50+ Cancer Types — from a single blood sample

  • 4x as many cancers were detected through screening when Galleri was added to usual NHS care, compared with usual NHS screening alone

  • <1/200 False Positive Cases — 99.6% Specificity

  • 93% accuracy for cancer signal of origin — this guides an efficient diagnostic work-up

The science: how it works

  1. Blood sample — A single sample, no special prep

  2. cfDNA extraction — DNA shed by cells is isolated

  3. Methylation sequencing — Reads DNA methylation patterns

  4. Methylation patterns classification — Determines if a cancer signal is present

  5. Cancer Signal Origin — Predicts most likely tissue of origin

Who it’s for

Galleri is intended as an addition to standard screening for adults at higher risk of cancer:

  • Typically those aged 50 and over (but at least age 22).

  • Individuals with a personal history of cancer, smokers or former smokers

  • Anyone wishing to take a proactive approach with their health

Cancer screening tests.

For peace of mind.